163 related articles for article (PubMed ID: 33547046)
1. Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography.
Eriksson O; Velikyan I; Haack T; Bossart M; Evers A; Lorenz K; Laitinen I; Larsen PJ; Plettenburg O; Johansson L; Pierrou S; Wagner M
Diabetes; 2021 Apr; 70(4):842-853. PubMed ID: 33547046
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a fatty acid chain modification to prolong circulatory half-life of a radioligand towards glucose-dependent insulinotropic polypeptide receptor.
Khalil A; Hakhverdyan S; Cheung P; Bossart M; Wagner M; Eriksson O; Velikyan I
Nucl Med Biol; 2024; 128-129():108876. PubMed ID: 38241936
[TBL] [Abstract][Full Text] [Related]
3. Human GIP(3-30)NH
Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
[TBL] [Abstract][Full Text] [Related]
4. The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
Gourni E; Waser B; Clerc P; Fourmy D; Reubi JC; Maecke HR
J Nucl Med; 2014 Jun; 55(6):976-82. PubMed ID: 24744444
[TBL] [Abstract][Full Text] [Related]
5. Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences.
Velikyan I; Bossart M; Haack T; Laitinen I; Estrada S; Johansson L; Pierrou S; Wagner M; Eriksson O
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678558
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
8. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
[TBL] [Abstract][Full Text] [Related]
9. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
10. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
11. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Verma MK; Goel R; Krishnadas N; Nemmani KVS
Expert Opin Ther Targets; 2018 Jul; 22(7):615-628. PubMed ID: 29911915
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
[TBL] [Abstract][Full Text] [Related]
13. Expression of glucose-dependent insulinotropic polypeptide and its receptor in the rat major salivary glands.
Privatananupunt J; Watari I; Podyma-Inoue KA; Kubono M; Ono T
Acta Histochem; 2014 May; 116(4):545-50. PubMed ID: 24360021
[TBL] [Abstract][Full Text] [Related]
14. GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner.
Teng L; Guan T; Guo B; Ma C; Lin G; Wu R; Xu M; Liu M; Liu Y
Biochem Biophys Res Commun; 2021 Jan; 534():121-127. PubMed ID: 33321289
[TBL] [Abstract][Full Text] [Related]
15. The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system.
Adriaenssens AE; Gribble FM; Reimann F
Peptides; 2020 Mar; 125():170194. PubMed ID: 31697967
[TBL] [Abstract][Full Text] [Related]
16. Temporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats.
Marcos AB; Forner S; Martini AC; Patrício ES; Clarke JR; Costa R; Felix-Alves J; Vieira VJ; de Andrade EL; Mazzuco TL; Calixto JB; Figueiredo CP
J Neurotrauma; 2016 Feb; 33(3):261-8. PubMed ID: 26421658
[TBL] [Abstract][Full Text] [Related]
17. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
18. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
19. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
[TBL] [Abstract][Full Text] [Related]
20. Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the
Bowker N; Hansford R; Burgess S; Foley CN; Auyeung VPW; Erzurumluoglu AM; Stewart ID; Wheeler E; Pietzner M; Gribble F; Reimann F; Bhatnagar P; Coghlan MP; Wareham NJ; Langenberg C
Diabetes; 2021 Nov; 70(11):2706-2719. PubMed ID: 34426508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
